These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 309414)

  • 1. Quantitative tests of nitrogen metabolism in cirrhosis: relation to other manifestations of liver disease.
    Ansley JD; Isaacs JW; Rikkers LF; Kutner MH; Nordlinger BM; Rudman D
    Gastroenterology; 1978 Oct; 75(4):570-9. PubMed ID: 309414
    [No Abstract]   [Full Text] [Related]  

  • 2. [Several factors in the pathogenesis of hepatic failure in patients with liver cirrhosis and bleeding from esophageal and gastric varicose veins].
    Bour AV; Manuk'ian GV; Umruzakov IU; Shertsinger AG
    Anesteziol Reanimatol; 1993; (2):32-4. PubMed ID: 7943876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic coma in cirrhosis of the liver. The course and prognosis of 100 consecutive coma episodes.
    Prytz H; Sloth K
    Scand J Gastroenterol; 1973; 8(3):229-33. PubMed ID: 4724923
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors participating in the development and mortality of variceal bleeding in portal hypertension--possible effects of the kidney damage and malnutrition.
    Lata J; Husová L; Juránková J; Senkyrík M; Díte P; Dastych M; Dastych M; Kroupa R
    Hepatogastroenterology; 2006; 53(69):420-5. PubMed ID: 16795985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effect of various amino acids upon the blood ammonia concentration of patients with liver disease.
    Rudman D; Galambos JT; Smith RB; Salam AA; Warren WD
    Am J Clin Nutr; 1973 Sep; 26(9):916-25. PubMed ID: 4727750
    [No Abstract]   [Full Text] [Related]  

  • 6. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis.
    Marchesini G; Fabbri A; Bianchi G; Brizi M; Zoli M
    Hepatology; 1996 May; 23(5):1084-92. PubMed ID: 8621138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 9- -fluorohydrocortisone induced ascites in alcoholic liver disease.
    Denison EK; Lieberman FL; Reynolds TB
    Gastroenterology; 1971 Oct; 61(4):497-503. PubMed ID: 5114641
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of protein metabolism in 204 liver cirrhotics with and without hepatic encephalopathy. I. Clinical and general biochemical findings.
    Müting D; Kalk JF; Koussouris P; Motschenbacher MT; Rausche A
    Hepatogastroenterology; 1986 Apr; 33(2):61-5. PubMed ID: 3721388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the effect of neomycin on blood ammonia, free amino acids and free phenols in serum and urine in liver cirrhosis].
    Müting D; Reikowski J; Reikowski H
    Med Welt; 1968 May; 19():1235-9. PubMed ID: 5728824
    [No Abstract]   [Full Text] [Related]  

  • 10. The prognostic value of laboratory tests in liver disease.
    Tygstrup N
    Scand J Gastroenterol Suppl; 1973; 19():47-50. PubMed ID: 4123936
    [No Abstract]   [Full Text] [Related]  

  • 11. Portal surgery and liver function: a new look at an old problem.
    Galambos JT; Warren WD; Rudman D
    Mt Sinai J Med; 1976; 43(3):219-25. PubMed ID: 1084465
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical profiles.
    Stat Bull Metropol Life Insur Co; 1969 Oct; 50():2-9. PubMed ID: 5374120
    [No Abstract]   [Full Text] [Related]  

  • 13. Albumin-based dialysis as an effective treatment for severe traumatic hepatic necrosis.
    Ben-Abraham R; Szold O; Nimrod A; Sorkine P
    Isr Med Assoc J; 2003 Jun; 5(6):455-6. PubMed ID: 12841026
    [No Abstract]   [Full Text] [Related]  

  • 14. KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications.
    Korean Association for the Study of the Liver (KASL)
    Clin Mol Hepatol; 2020 Apr; 26(2):83-127. PubMed ID: 31918536
    [No Abstract]   [Full Text] [Related]  

  • 15. Corticosteroid-induced changes in urea metabolism in patients with hepatocellular disease.
    Jones EA; Cain GD; Dickinson G
    Gastroenterology; 1972 Apr; 62(4):612-7. PubMed ID: 5020873
    [No Abstract]   [Full Text] [Related]  

  • 16. [Extension of indications for portal shunt operation through the management of postoperative liver decompensation with peritoneal dialysis].
    Kraemer HJ
    Munch Med Wochenschr; 1968 Feb; 110(7):406-9. PubMed ID: 5695059
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-invasive model predicting clinically-significant portal hypertension in patients with advanced fibrosis.
    Park SH; Park TE; Kim YM; Kim SJ; Baik GH; Kim JB; Kim DJ
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1289-93. PubMed ID: 19682196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease.
    Zaman A; Hapke R; Flora K; Rosen HR; Benner K
    Am J Gastroenterol; 1999 Nov; 94(11):3292-6. PubMed ID: 10566732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic amino-nitrogen clearance to urea-nitrogen in control subjects and in patients with cirrhosis: a simplified method.
    Bianchi G; Marchesini G; Vilstrup H; Fabbri A; De Mitri MS; Zoli M; Pisi E
    Hepatology; 1991 Mar; 13(3):460-6. PubMed ID: 1999317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ammonia and fructose tolerance tests in cirrhosis of liver.
    Shah PK; Sanchette PC; Sharma NL; Singhvi NM
    J Assoc Physicians India; 1975 Nov; 23(11):737-42. PubMed ID: 1223071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.